177Lu-CTR-FAPI Treatment Group:177Lu-CTR-FAPI

2 trials

Sponsors

Peking Union Medical College Hospital, Shanghai General Hospital

Conditions

Advanced, metastatic solid tumors, preferably including pancreatic cancer, breast cancer, and soft tissue sarcoma.Thyroid cancer

Phase 1

Phase I Clinical Study of 177Lu-CTR-FAPI Injection in the Treatment of Thyroid Cancer

Active, not recruitingChiCTR2500103991

Peking Union Medical College HospitalThyroid cancer

Start: 2025-07-01Updated: 2025-06-16

Unknown Phase

A Single-Center, Single-Arm, Open-Label Clinical Study of 177Lu-CTR-FAPI Injection in the Treatment of Patients with Advanced, Metastatic Solid Tumors

Active, not recruitingChiCTR2500110002

Shanghai General HospitalAdvanced, metastatic solid tumors, preferably including pancreatic cancer, breast cancer, and soft tissue sarcoma.

Start: 2025-10-01Updated: 2025-10-06